24.09.2021 /
Berlin once again honors outstanding deep-tech companies - including MyoPax
A fundamentally new therapeutic approach to cystic fibrosis: Nanobody repairs cellular defect
Eckert & Ziegler: Metzler Initiates Coverage with a Buy Rating and a Price Target of € 21.00. Upside Potential: 41%
